Regulon: R-464
Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.
Regulon Summary
Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.
| Genes | Cox Hazard Ratio | Regulators | Causal Flows | Transcriptional Programs | Hallmarks |
|---|---|---|---|---|---|
| 9 | 3.14557 | 1 | 5 | Pr-108 |           |
Regulon Genes
List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.
| Entrez ID | EnsEMBL ID | Preferred Name | Uniprot ID |
|---|---|---|---|
| 9369 | ENSG00000021645 | NRXN3 | Q9HDB5 |
| 27122 | ENSG00000050165 | DKK3 | Q9UBP4 |
| 3241 | ENSG00000115756 | HPCAL1 | P37235 |
| 9645 | ENSG00000133816 | MICAL2 | O94851 |
| 9922 | ENSG00000144711 | IQSEC1 | Q6DN90 |
| 25924 | ENSG00000170011 | MYRIP | Q8NFW9 |
| 5464 | ENSG00000180817 | PPA1 | Q15181 |
| 2903 | ENSG00000183454 | GRIN2A | Q12879 |
| 29 | ENSG00000278741 | ABR | Q12979 |
Regulon Drugs
| Name | Approved Symbol | Type | Action Type | Mechanism of Action | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|---|
| ACAMPROSATE CALCIUM | GABRG2 | Small molecule | POSITIVE MODULATOR | GABA-A receptor; anion channel positive modulator | 4 | 0 |
| AV-101 | GRIN1 | Small molecule | ANTAGONIST | Glutamate [NMDA] receptor antagonist | 2 | 0 |
| MEMANTINE | GRIN1 | Small molecule | NEGATIVE ALLOSTERIC MODULATOR | Glutamate [NMDA] receptor negative allosteric modulator | 4 | 2 |
| DEXTROMETHORPHAN HYDROBROMIDE | GRIN2A | Small molecule | AGONIST | Sigma opioid receptor agonist | 4 | 0 |
| MEMANTINE HYDROCHLORIDE | GRIN1 | Small molecule | NEGATIVE ALLOSTERIC MODULATOR | Glutamate [NMDA] receptor negative allosteric modulator | 4 | 0 |
| ORPHENADRINE HYDROCHLORIDE | SCN2A | Small molecule | BLOCKER | Sodium channel alpha subunit blocker | 4 | 0 |
| NERAMEXANE | GRIN1 | Small molecule | ANTAGONIST | Neuronal acetylcholine receptor; alpha9/alpha10 antagonist | 3 | 0 |
| KETAMINE | GRIN1 | Small molecule | NEGATIVE ALLOSTERIC MODULATOR | Glutamate [NMDA] receptor negative allosteric modulator | 4 | 0 |
| DEXTROMETHORPHAN POLISTIREX | GRIN2A | Small molecule | ANTAGONIST | Glutamate [NMDA] receptor subunit epsilon 1 antagonist | 4 | 0 |
| DEXTROMETHORPHAN | GRIN2A | Small molecule | AGONIST | Sigma opioid receptor agonist | 4 | 0 |
| ORPHENADRINE | SCN2A | Small molecule | BLOCKER | Sodium channel alpha subunit blocker | 4 | 0 |
| FELBAMATE | GRIN1 | Small molecule | ANTAGONIST | Glutamate [NMDA] receptor antagonist | 4 | 0 |
| AMANTADINE HYDROCHLORIDE | GRIN1 | Small molecule | ANTAGONIST | Glutamate [NMDA] receptor antagonist | 4 | 0 |
| RAPASTINEL | GRIN1 | Protein | PARTIAL AGONIST | Glutamate [NMDA] receptor partial agonist | 3 | 0 |
| LANICEMINE | GRIN1 | Small molecule | BLOCKER | Glutamate [NMDA] receptor blocker | 2 | 0 |
| ACAMPROSATE | GABRG2 | Small molecule | POSITIVE MODULATOR | GABA-A receptor; anion channel positive modulator | 4 | 0 |
| RALFINAMIDE | MAOB | Small molecule | INHIBITOR | Monoamine oxidase B inhibitor | 3 | 0 |
| GW468816 | GRIN1 | Small molecule | ANTAGONIST | Glutamate [NMDA] receptor antagonist | 2 | 0 |
| NERAMEXANE MESYLATE | GRIN1 | Small molecule | ANTAGONIST | Neuronal acetylcholine receptor; alpha9/alpha10 antagonist | 3 | 0 |
| ORPHENADRINE CITRATE | SCN2A | Small molecule | BLOCKER | Sodium channel alpha subunit blocker | 4 | 0 |
| APIMOSTINEL | GRIN1 | Protein | PARTIAL AGONIST | Glutamate [NMDA] receptor partial agonist | 2 | 0 |
| ESKETAMINE | GRIN1 | Small molecule | NEGATIVE ALLOSTERIC MODULATOR | Glutamate [NMDA] receptor negative allosteric modulator | 4 | 0 |
| INDANTADOL | GRIN1 | Small molecule | INHIBITOR | Monoamine oxidase A inhibitor | 2 | 0 |
| ESKETAMINE HYDROCHLORIDE | GRIN1 | Small molecule | NEGATIVE ALLOSTERIC MODULATOR | Glutamate [NMDA] receptor negative allosteric modulator | 4 | 0 |
| AMANTADINE | GRIN1 | Small molecule | ANTAGONIST | Glutamate [NMDA] receptor antagonist | 4 | 0 |
| KETAMINE HYDROCHLORIDE | GRIN1 | Small molecule | NEGATIVE ALLOSTERIC MODULATOR | Glutamate [NMDA] receptor negative allosteric modulator | 4 | 0 |
Causal Flows
Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.